Tagged: National Institutes of Health (NIH)

A culture of discovery and collaboration among faculty carries potential to “completely shake up their fields of study.”

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has awarded the UCSF Department of Bioengineering & Therapeutic Sciences (BTS) and the

You may have read the recent news about UCSF being the top public recipient of biomedical research grants from the National Institutes of Health (NIH).

For the 37th consecutive year, the UCSF School of Pharmacy has received more funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States. School researchers were awarded $28.2 million in grants during NIH’s 2016 fiscal year, from October 1, 2015 to...

For the 35th consecutive year, the UCSF School of Pharmacy has received more funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.

School researchers were awarded $31.8 million during the 2014 fiscal year, from October 1, 2013 to September 30,...

For the 34th consecutive year, the UCSF School of Pharmacy has received more research funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.

School researchers were awarded $29.2 million during the 2013 NIH fiscal year, from October 1, 2012 to...

Zev Gartner, PhD, has been named a recipient of the 2013 National Institutes of Health (NIH) Director’s New Innovator Award, which will provide his lab with up to $1.5 million in research funding over the next five years.

The San Francisco Chronicle and the Bay Area News Group, which includes the San Jose Mercury News and Oakland Tribune, have published feature articles this week focused on The Kidney Project, an effort to develop the first implantable bioartificial kidney to treat end-stage renal disease.

The effort to create the first implantable bioartificial kidney has received a $750,000 gift from the John and Marcia Goldman Foundation.

A promising new way to fight human herpes viruses and a drug delivery device to better treat a major cause of blindness have won development funding from UCSF’s Clinical and Translational Science Institute (CTSI).